BEIJING, Jan. 10, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that it has received Conformite Europeenne (CE) certification for its sleep diagnostic devices and air compressors.
Dehaier's DHR-998 sleep diagnostic device collects data on patients' respiration flow, pulse, oximetry, thoracoabdominal breathing, snoring and body position. Dehaier's air compressors are key supplemental devices for medical ventilators. The CE mark recognizes that the two products meet European Union (EU) health and safety standards and are approved for sale in the 27 member states of the EU and in the four members of the European Free Trade Association (EFTA).
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical stated, "We are thrilled to obtain the CE marking, which validates the high quality and manufacturing standards of Dehaier's innovative medical products. This lays a strong foundation for us to offer our sleep diagnostic devices and air compressors in the EU markets. Moreover, we intend to leverage this approval to further expand our distribution network in the European Union as well as other markets that rely on the CE mark process.""We already ship our air compressor products to the Czech Republic, Hungary, Kyrgyzstan, Pakistan, Ukraine, and the Philippines. Following the CE approval, we will continue to seek more distribution and OEM opportunities worldwide," said Ms. Rayna Dong, Director of Dehaier's International Marketing. "The CE marking strengthens our ability to cooperate with potential distributors from EU countries. In the near term, we look to establish a strong footprint in the European market, which presents an enormous potential for Dehaier's medical equipment and homecare products." About Dehaier Medical Systems Ltd. Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD ( Italy), Welch Allyn ( USA), HEYER ( Germany), Timesco (UK), eVent Medical (US) and JMS ( Japan). Dehaier's technology is based on five patents and five software copyrights; additionally Dehaier has three pending patents, six pending software copyrights and proprietary technology. More information may be found at http://www.chinadhr.com. Forward-looking Statements This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's international growth plans and prospects(such as any plans to expand into European markets), future acceptance of its products in China and abroad, receipt of regulatory approvals for Dehaier's products, the impact of receipt of such approvals on business prospects and results of relationships with distributors. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. Contact Us Dehaier Medical Systems Limited Surie Liu+86 10-5166-0080 firstname.lastname@example.org Dehaier Medical Systems Limited Lisa Zhou+86 10-5166-0080 email@example.com SOURCE Dehaier Medical Systems Ltd.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.